Chiusura precedente | 834,11 |
Aperto | 830,00 |
Denaro | N/D x N/D |
Lettera | N/D x N/D |
Min-Max giorno | 827,20 - 845,60 |
Intervallo di 52 settimane | 827,20 - 845,60 |
Volume | |
Media Volume | N/D |
Capitalizzazione | 19,902B |
Beta (5 anni mensile) | 0,35 |
Rapporto PE (ttm) | 0,39 |
EPS (ttm) | 21,50 |
Prossima data utili | N/D |
Rendimento e dividendo (forward) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | N/D |
Bagsværd, Denmark, 23 January 2023 – On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period beginning 2 February 2022. Under the programme
NEW YORK, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a leading global data analytics and digital operations and solutions company, today announced that Andreas Fibig, a seasoned global executive with a strong record of innovation across industries and geographies, has been appointed to EXL’s Board of Directors as an independent director effective Jan. 10, 2023. Fibig will be a member of the Board’s Audit and Nominating and Governance Committees. “Andreas is a dis
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 22 December 2022 – On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period